Unknown

Dataset Information

Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.


ABSTRACT:

Importance

Earlier studies on the cost of muscle-invasive bladder cancer treatments lack granularity and are limited to 180 days.

Objective

To compare the 1-year costs associated with trimodal therapy vs radical cystectomy, accounting for survival and intensity effects on total costs.

Design, setting, and participants

This population-based cohort study used the US Surveillance, Epidemiology, and End Results-Medicare database and included 2963 patients aged 66 to 85 years who had received a diagnosis of clinical stage T2 to T4a muscle-invasive bladder cancer from January 1, 2002, through December 31, 2011. The data analysis was performed from March 5, 2018, through December 4, 2018.

Main outcomes and measures

Total Medicare costs within 1 year of diagnosis follo

SUBMITTER: Williams SB 

PROVIDER: S-EPMC6551585 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature